Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential regulatory role of RNA methylation in ovarian cancer. | RNA Biol | 2023 | 37194218 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. | BMC Med Genomics | 2023 | 37194014 | PubTator, text mining | PubMed |
| m6A eraser ALKBH5 mitigates the apoptosis of cardiomyocytes in ischemia reperfusion injury through m6A/SIRT1 axis. | PeerJ | 2023 | 37193033 | PubTator, text mining | PubMed |
| Intertwined regulation between RNA m6A modification and cancer metabolism. | Cell Insight | 2023 | 37192910 | PubTator, text mining | PubMed |
| Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox. | Biochemistry | 2023 | 37192099 | PubTator, text mining | PubMed |
| Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators. | Aging Dis | 2023 | 37191431 | PubTator, text mining | PubMed |
| SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37190199 | PubTator, text mining | PubMed |
| Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37189494 | PubTator, text mining | PubMed |
| The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets. | Biomolecules | 2023 | 37189411 | PubTator, text mining | PubMed |
| Preliminary study based on methylation and transcriptome gene sequencing of lncRNAs and immune infiltration in hypopharyngeal carcinoma. | Front Oncol | 2023 | 37182154 | PubTator, text mining | PubMed |
| The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. | Front Oncol | 2023 | 37182151 | PubTator, text mining | PubMed |
| Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer. | Mediators Inflamm | 2023 | 37181810 | PubTator, text mining | PubMed |
| ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 37181232 | PubTator, text mining | PubMed |
| Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. | Clin Epigenetics | 2023 | 37179374 | PubTator, text mining | PubMed |
| Identification of m6A-related lncRNAs as prognostic signature within colon tumor immune microenvironment. | Cancer Rep (Hoboken) | 2023 | 37178411 | PubTator, text mining | PubMed |
| Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment. | Aging (Albany NY) | 2023 | 37178254 | PubTator, text mining | PubMed |
| The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma. | Int J Mol Sci | 2023 | 37175660 | PubTator, text mining | PubMed |
| Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. | Int J Mol Sci | 2023 | 37175579 | PubTator, text mining | PubMed |
| Advances in the Anti-Tumor Activity of Biflavonoids in Selaginella. | Int J Mol Sci | 2023 | 37175435 | PubTator, text mining | PubMed |
| Hypericin Ameliorates Depression-like Behaviors via Neurotrophin Signaling Pathway Mediating m6A Epitranscriptome Modification. | Molecules | 2023 | 37175269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=58